M4MM
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Georgia Expands Access to Medical Cannabis
ATLANTA – A revised medical Cannabis law takes effect in Georgia on Wednesday, broadening the conditions that qualify patients for legal access and permitting vaporization as an approved method of use for the first time. ...
GCNC-Whitney Economics Report Provides Updated Insights on EU & UK Cannabis Markets
LONDON – The Global Cannabis Network Collective (GCNC) and Whitney Economics released What You Need to Know: EU & UK Cannabis Market Update this week at the Cannabis Europa 2026 conference in London, presenting a ...
Chisora Fights Back Against Chronic Pain with New UK Medical Cannabis Platform
LONDON – British heavyweight boxer Derek Chisora has gone public sharing his experience using prescribed medical Cannabis to manage chronic pain and launching a telehealth and patient education platform, WarOnPain, to guide others through the ...
Curaleaf Announces 1-for-3 Reverse Stock Split to Clear Path for U.S. Exchange Listing
STAMFORD – Curaleaf Holdings Inc. has announced a 1-for-3 reverse stock split of its subordinate voting shares, set to take effect on or about June 5, 2026. The move, approved by the company's Board of ...
Cannabis Vape Pens Are Safer Than Joints, California NORML Study Finds
LOS ANGELES – California NORML has released results from what it calls a first-of-its-kind pilot study comparing the emissions of licensed Cannabis vape pens against pre-roll joints, and the difference, by nearly every chemical measure ...
Helus Pharma Advances Phase 3 Trial for Novel Therapy in MDD
NEW YORK – Helus Pharma, the business name now used by Cybin Inc., announced that enrollment in its APPROACH Phase 3 trial has passed the 86% mark. The trial is testing HLP003, the company's lead ...
Hemp THC Beverages Return to Ohio Shelves
CLEVELAND – Hemp-derived THC drinks are back on a limited number of Ohio shelves after U.S. District Judge Jeffrey Helmick temporarily blocked the state from enforcing its newest hemp licensing law against a group of ...
Georgia Expands Access to Medical Cannabis
ATLANTA – A revised medical Cannabis law takes effect in Georgia on Wednesday, broadening the conditions that qualify patients for legal access and permitting vaporization as an approved method of use for the first time. ...
Cannabis Stocks Rally as U.S. Rescheduling Debate Heats Up
LOS ANGELES — For the first time in more than a year, cannabis stocks are enjoying a sustained rally. Exchange-traded funds focused on the sector have climbed sharply in recent weeks, and several of the ...
Did Psilocybin Arrive From Outer Space? New Genomic Study Opens the Door to a Cosmic Possibility
LOS ANGELES — The psychedelic compound psilocybin has long intrigued researchers for its potential to treat mental health conditions, but a groundbreaking study is now shedding new light on where these mushrooms came from—and it’s ...
Will Hope Fuel Cannabis Industry Growth Beyond Q2 2025?
LOS ANGELES – If you’ve been scrolling through the latest updates on the Highly Capitalized Network’s website or LinkedIn, you’ve likely caught the wave of Q2 2025 earnings reports sparking cautious optimism across the Cannabis ...
TerrAscend Reports Q2 2025 Financial Results
TORONTO – TerrAscend Corp. released its financial results for the second quarter of 2025, highlighting stable performance and strategic shifts. The company reported net revenue of $65 million, a slight decline from $67.2 million in ...
Ascend Wellness Holdings Reports Q2 2025 Financial Results
NEW YORK – Ascend Wellness Holdings, Inc., a multi-state Cannabis operator, shared its financial performance for the second quarter of 2025, confirming steady performance, a fortified balance sheet, and ongoing retail growth. The company recorded ...
Cronos Group Inc Reports Q2 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
MariMed Reports Q2 2025 Financial Results
NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...
Will the Hemp Beverage Category Still Be Here in 12 Months?
LOS ANGELES- Will the Hemp Beverage Category Still Be Here in 12 Months? That's not just a provocative question—it’s a quiet but growing concern across the hemp industry. After a explosive rise in popularity, hemp-derived THC ...
Verano Holdings Corp Reports Q2 2025 Financial Results
CHICAGO – Verano Holdings Corp., a multi-state Cannabis operator, released its financial results for the second quarter of 2025, reflecting a period of operational streamlining amid market challenges. The consolidated financial statements, prepared under U.S. ...
Curaleaf Reports Q2 2025 Financial Results
STAMFORD – Curaleaf Holdings, Inc., a major player in the global Cannabis market, released its financial and operational results for the second quarter of 2025, ending June 30, showcasing a blend of domestic resilience and ...
GTI Reports Q2 2025 Financial and Operational Results
CHICAGO & VANCOUVER – Green Thumb Industries Inc., a major player in the U.S. Cannabis market, national Cannabis consumer packaged goods (CPG) company, and operator of RISE Dispensaries, reported its financial and operational results for ...
Trulieve Cannabis Corp Reports Q2 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., a major player in the U.S. Cannabis market, announced its financial and operational results for the second quarter of 2025, ending June 30, showcasing resilience and strategic progress. The company ...
Aurora Cannabis Reports Q1 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. (ACB), a leading Canadian Cannabis producer, announced its financial and operational results for the first quarter of fiscal 2026, ending June 30, 2025, showcasing robust growth in its medical Cannabis ...
